Syndax Pharmaceuticals Inc (SNDX)
EBITDA Margin
-50.40%
Quarterly · Period ending:
SNDX EBITDA Margin
Latest reported-50.40%period ending
Latest reported-50.40%period ending
SNDX Quarterly EBITDA Margin (0.00% → -50.40%)
Quarterly ebitda margin
High-resolution chart · PNG
SNDX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -50.3957% | |
| -47.5194% | |
| -22.3551% | |
| -114.2966% | |
| -168.4335% | |
| -462.9428% | |
| -1,163.5807% | |
| -672.808% | |
| -1,943.2857% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 76.0081% | |
| -161.4707% | |
| -5,875.1979% | |
| -7,146.1741% | |
| -5,226.3158% | |
| -5,218.7335% | |
| -4,327.7045% | |
| -3,895.5145% | |
| -3,620.7895% | |
| -3,371.7678% | |
| -3,935.6201% | |
| -3,726.1214% | |
| -4,992.8947% | |
| -4,669.1293% | |
| -4,980.4749% | |
| -5,194.9868% | |
| -1,653.1433% | |
| -5,013.7705% | |
| -4,514.4262% | |
| -4,318.3607% | |
| -3,627.541% | |
| -4,996.0656% | |
| -2,829.5082% | |
| -2,852.459% | |
| -2,196.3934% | |
| -1,858.3607% | |
| -29,558.8235% | |
| 0% | |
| 0% | |
| -644.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |